These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25362349)

  • 1. GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.
    Ho WL; Chou CH; Jeng YM; Lu MY; Yang YL; Jou ST; Lin DT; Chang HH; Lin KH; Hsu WM; Huang MC
    Oncotarget; 2014 Dec; 5(23):12247-59. PubMed ID: 25362349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma.
    Chang HH; Chen CH; Chou CH; Liao YF; Huang MJ; Chen YH; Wang WJ; Huang J; Hung JS; Ho WL; Jeng YM; Che MI; Lee H; Lu MY; Yang YL; Jou ST; Lin DT; Lin KH; Hsu WM; Huang MC
    Clin Cancer Res; 2013 Apr; 19(7):1705-16. PubMed ID: 23444218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation.
    Liu SY; Shun CT; Hung KY; Juan HF; Hsu CL; Huang MC; Lai IR
    Oncotarget; 2016 Mar; 7(10):11251-62. PubMed ID: 26848976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
    Wu YM; Liu CH; Hu RH; Huang MJ; Lee JJ; Chen CH; Huang J; Lai HS; Lee PH; Hsu WM; Huang HC; Huang MC
    Cancer Res; 2011 Dec; 71(23):7270-9. PubMed ID: 21990321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma.
    Ho WL; Che MI; Chou CH; Chang HH; Jeng YM; Hsu WM; Lin KH; Huang MC
    Cancer Sci; 2013 Dec; 104(12):1600-8. PubMed ID: 24118321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.
    Sun Z; Xue H; Wei Y; Wang C; Yu R; Wang C; Wang S; Xu J; Qian M; Meng Q; Li G
    Clin Sci (Lond); 2019 May; 133(10):1167-1184. PubMed ID: 31076460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
    Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC
    Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma.
    Chang HH; Lee H; Hu MK; Tsao PN; Juan HF; Huang MC; Shih YY; Wang BJ; Jeng YM; Chang CL; Huang SF; Tsay YG; Hsieh FJ; Lin KH; Hsu WM; Liao YF
    Clin Cancer Res; 2010 Sep; 16(17):4411-20. PubMed ID: 20736329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B4GALNT3 expression predicts a favorable prognosis and suppresses cell migration and invasion via β₁ integrin signaling in neuroblastoma.
    Hsu WM; Che MI; Liao YF; Chang HH; Chen CH; Huang YM; Jeng YM; Huang J; Quon MJ; Lee H; Huang HC; Huang MC
    Am J Pathol; 2011 Sep; 179(3):1394-404. PubMed ID: 21741930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of GALNT2 in human extravillous trophoblasts and its suppressive role in trophoblast invasion.
    Liao WC; Chen CH; Liu CH; Huang MJ; Chen CW; Hung JS; Chou CH; Chen CH; Che MI; Chang HM; Lan CT; Huang HC; Tseng GF; Shyu MK; Huang MC
    Placenta; 2012 Dec; 33(12):1005-11. PubMed ID: 23117232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
    Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
    Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of insulin receptor-related receptor and insulin-like growth factor 1 receptor correlates with enhanced apoptosis and dedifferentiation in human neuroblastomas.
    Weber A; Huesken C; Bergmann E; Kiess W; Christiansen NM; Christiansen H
    Clin Cancer Res; 2003 Nov; 9(15):5683-92. PubMed ID: 14654552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer.
    Hu Q; Tian T; Leng Y; Tang Y; Chen S; Lv Y; Liang J; Liu Y; Liu T; Shen L; Dong X
    Cell Mol Biol Lett; 2022 Sep; 27(1):71. PubMed ID: 36058918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach.
    Otake K; Uchida K; Ide S; Kobayashi Y; Kobayashi I; Kusunoki M
    Pediatr Blood Cancer; 2016 Feb; 63(2):221-7. PubMed ID: 26469522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The O-glycosylating enzyme GALNT2 suppresses the malignancy of gastric adenocarcinoma by reducing EGFR activities.
    Hu WT; Yeh CC; Liu SY; Huang MC; Lai IR
    Am J Cancer Res; 2018; 8(9):1739-1751. PubMed ID: 30323967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calreticulin expression in neuroblastoma--a novel independent prognostic factor.
    Hsu WM; Hsieh FJ; Jeng YM; Kuo ML; Chen CN; Lai DM; Hsieh LJ; Wang BT; Tsao PN; Lee H; Lin MT; Lai HS; Chen WJ
    Ann Oncol; 2005 Feb; 16(2):314-21. PubMed ID: 15668290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma.
    Yco LP; Geerts D; Koster J; Bachmann AS
    Int J Oncol; 2013 Apr; 42(4):1408-16. PubMed ID: 23440329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZAR1 knockdown promotes the differentiation of human neuroblastoma cells by suppression of MYCN expression.
    Watanabe Y; Ishizuka Y; Hirano T; Nagasaki-Maeoka E; Hoshi R; Yoshizawa S; Uekusa S; Kawashima H; Sugito K; Shinohara K; Fukuda N; Nagase H; Soma M; Koshinaga T; Fujiwara K
    Med Oncol; 2017 Aug; 34(9):158. PubMed ID: 28791558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CFC1 is a cancer stemness-regulating factor in neuroblastoma.
    Chikaraishi K; Takenobu H; Sugino RP; Mukae K; Akter J; Haruta M; Kurosumi M; Endo TA; Koseki H; Shimojo N; Ohira M; Kamijo T
    Oncotarget; 2017 Jul; 8(28):45046-45059. PubMed ID: 28620148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes mellitus facilitates endometrial hyperplasia progression by activating the proliferative function of mucin O-glycosylating enzyme GALNT2.
    Zhou X; Xu Y; Yin D; Zhao F; Hao Z; Zhong Y; Zhang J; Zhang B; Yin X
    Biomed Pharmacother; 2020 Nov; 131():110764. PubMed ID: 33152927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.